SPC464

Rósanólixisúmab

  • Status:
    Veitt
  • Application date:
    26.4.2024
  • Application published:
    15.5.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    12.5.2038
  • Medicine name:
    Rystiggo
  • Medicine for children:
    No

Timeline

Today
26.4.2024Application
15.5.2024Publication
15.12.2025Registration
12.5.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1780
  • Date:
    10.1.2024
  • Foreign authorization number:
    EU/1/23/1780
  • Date:
    5.1.2024

Owner

  • Name:
    UCB Biopharma SRL
  • Address:
    Allé de la Recherche 60, 1070 Brussels BE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents